홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Carbonate → (S)-3-(4-(5-Chloropyridazin-3-yl)phenyl)-5,5-dimethyl-4-phenyloxazolidin-2-one

HRID 525346
인쇄

반응식

HRID 525346 반응식
[CH3:1][C:2]1([CH3:29])[O:6][C:5](=[O:7])[N:4]([C:8]2[CH:13]=[CH:12][C:11](B3OC(C)(C)C(C)(C)O3)=[CH:10][CH:9]=2)[C@H:3]1[C:23]1[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=1.Cl[C:31]1[N:32]=[N:33][CH:34]=[C:35]([Cl:37])[CH:36]=1.C([O-])([O-])=O.[Na+].[Na+]>C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1.O1CCOCC1>[Cl:37][C:35]1[CH:36]=[C:31]([C:11]2[CH:12]=[CH:13][C:8]([N:4]3[C@@H:3]([C:23]4[CH:24]=[CH:25][CH:26]=[CH:27][CH:28]=4)[C:2]([CH3:29])([CH3:1])[O:6][C:5]3=[O:7])=[CH:9][CH:10]=2)[N:32]=[N:33][CH:34]=1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

6

반응물 3

HCID 10340Sodium CarbonateHCID 199596873,5-DichloropyridazineHCID 89813960(S)-5,5-dimethyl-4-phenyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)oxazolidin-2-one2회

생성물 1

HCID 89813458(S)-3-(4-(5-Chloropyridazin-3-yl)phenyl)-5,5-dimethyl-4-phenyloxazolidin-2-one수율 25.02%

시약·촉매·용매 2

HCID 178418397
HCID 178418397, 화합물
촉매
HCID 312751,4-Dioxane용매

실험 절차

To a 0.5-2.0 mL microwave vial charged with (S)-5,5-dimethyl-4-phenyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)oxazolidin-2-one (Intermediate J) (0.240 g, 0.610 mmol) and 3,5-dichloropyridazine (commercially available from ACES Pharma, Princeton, N.J.) (0.100 g, 0.671 mmol) were added dioxane (1.220 mL), and 2 M Na2CO3 (1.220 mL). Nitrogen was bubbled through the resulting suspension and then Pd(PPh3)4 (0.071 g, 0.061 mmol) was added. The resulting mixture was irradiated at 100° C. for 30 minutes. LC-MS indicated the formation of product as a major species (two close peaks with product mass, likely isomers) along with other impurities with consumption of starting material. The dark suspension was diluted with water, transferred to a separatory funnel, and extracted with EtOAc (2×). The combined organic layers were dried with Na2SO4, filtered, and dried under reduced pressure. The residual material was purified with a 40 g HP 15 μm spherical silica column (Interchim) ramping EtOAc in heptane from 0-100% leading to isolation of product (primarily one isomer) as the major species with 10-15% impurity. (S)-3-(4-(5-Chloropyridazin-3-yl)phenyl)-5,5-dimethyl-4-phenyloxazolidin-2-one (0.058 g, 0.153 mmol, 25.02% yield) was obtained as a white solid. Note: the regiochemistry of the product was not confirmed, but it was assumed that the major product would result from the more reactive chloride). m/z (ESI) 380.1 (M+H)+.

후처리

  1. customNitrogen was bubbled through the resulting suspension
  2. customThe resulting mixture was irradiated at 100° C. for 30 minutes
  3. customclose peaks with product mass, likely isomers) along with other impurities
  4. customwith consumption of starting material
  5. additionThe dark suspension was diluted with water
  6. customtransferred to a separatory funnel
  7. extractionextracted with EtOAc (2×)
  8. dry with materialThe combined organic layers were dried with Na2SO4
  9. filtrationfiltered
  10. customdried under reduced pressure
  11. customThe residual material was purified with a 40 g HP 15 μm spherical silica column (Interchim)

출처 및 근거

ORD 기록
ord-cd79f83b30cf400e9367d85fbdfece6f
출처 데이터셋
uspto-grants-2016_05
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US09340549B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트